February 19, 2014
A U.S. Securities and Exchange Commission case alleging two men traded on inside information supplied by Hunton & Williams LLP drug patent attorney Robert Schulman has spurred a criminal investigation, federal prosecutors revealed Tuesday.
January 02, 2014
The U.S. Securities and Exchange Commission has reached a settlement with one of two men accused of trading on inside information supplied by Hunton & Williams LLP drug patent attorney Robert Schulman, who was allegedly drunk at the time of the disclosure, according to a Monday court filing.
December 02, 2013
One of two men accused by the U.S. Securities and Exchange Commission of trading on inside information acquired from Hunton & Williams LLP drug patent attorney Robert Schulman suggested Monday that he cannot be held liable because Schulman was allegedly drunk at the time of the disclosure.
November 25, 2013
The U.S. Securities and Exchange Commission has begun settlement talks with one of two men accused of trading on inside information supplied by Hunton & Williams LLP drug patent attorney Robert Schulman, who was allegedly intoxicated at the time of the tip, according to a Friday filing in Florida district court.
September 24, 2013
Hunton & Williams LLP partner Robert M. Schulman is the Washington patent lawyer said by the U.S. Securities and Exchange Commission to have divulged confidential information about the acquisition of a client while intoxicated, a source confirmed to Law360 Tuesday.